Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,282.40
(
0.00%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
109.93
(
1.66%
)
Bitcoin
68,381.62
(
0.80%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 192587

Tuesday, 01/17/2017 12:44:57 PM

Tuesday, January 17, 2017 12:44:57 PM

Post# of 257269
PULM +140%(!) on QIDP designation for PUR1900:

http://finance.yahoo.com/news/pulmatrix-drug-candidate-receives-qualified-144500653.html

PUR1900 is intended to treat fungal infections in CF patients.

PULM is the result of a 2015 reverse merger (#msg-114559267).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today